{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:30:37Z","timestamp":1784892637586,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["597481"],"award-info":[{"award-number":["597481"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bone.2026.117898","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:09:53Z","timestamp":1776067793000},"page":"117898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Anabolic effect of parathyroid hormone (1\u201334) to prevent ovariectomy induced bone loss is attenuated in Col1A1-cre floxed monocyte chemotactic protein 1 (MCP1, CCL2) mice"],"prefix":"10.1016","volume":"209","author":[{"given":"Nigel","family":"Morrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchel","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desa","family":"Delumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Pettit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Millard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Forwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2026.117898_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bone.2026.117898_bb0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1302\/2046-3758.61.BJR-2016-0085.R1","article-title":"Parathyroid hormone 1-34 and skeletal anabolic action","volume":"6","author":"Osagie-Clouard","year":"2017","journal-title":"Bone Joint Res."},{"key":"10.1016\/j.bone.2026.117898_bb0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejphar.2015.03.028","article-title":"Animal models for osteoporosis","volume":"759","author":"Komori","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.bone.2026.117898_bb0020","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/jbmr.4389","article-title":"Anabolic actions of PTH in murine models: two decades of insights","volume":"36","author":"Zweifler","year":"2021","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2026.117898_bb0025","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1152\/physrev.00031.2015","article-title":"Parathyroid hormone-related protein, its regulation of cartilage and bone development, and role in treating bone diseases","volume":"96","author":"Martin","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bone.2026.117898_bb0030","doi-asserted-by":"crossref","first-page":"33086","DOI":"10.1074\/jbc.M705194200","article-title":"Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis","volume":"282","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"45","key":"10.1016\/j.bone.2026.117898_bb0035","doi-asserted-by":"crossref","first-page":"33098","DOI":"10.1074\/jbc.M611781200","article-title":"Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre\/osteoclasts","volume":"282","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2026.117898_bb0040","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/jbmr.1933","article-title":"Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone","volume":"28","author":"Tamasi","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2026.117898_bb0045","doi-asserted-by":"crossref","first-page":"15300","DOI":"10.1038\/s41598-017-15563-7","article-title":"Catabolic effects of human PTH (1-34) on bone: requirement of monocyte chemoattractant protein-1 in murine model of hyperparathyroidism","volume":"7","author":"Siddiqui","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2026.117898_bb0050","doi-asserted-by":"crossref","first-page":"16163","DOI":"10.1074\/jbc.M412713200","article-title":"MCP1 is induced by receptor activator of NF\u03baB ligand, promotes osteoclast fusion, and rescues GM-CSF suppression of osteoclast formation","volume":"280","author":"Kim","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bone.2026.117898_bb0055","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/ijc.22704","article-title":"PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro","volume":"121","author":"Lu","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.bone.2026.117898_bb0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbrc.2009.04.020","article-title":"MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine\/paracrine manner","volume":"383","author":"Miyamoto","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2026.117898_bb0065","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1158\/0008-5472.CAN-08-2164","article-title":"A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2026.117898_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115762","article-title":"Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone\u2019s anabolic actions in bone implicates TGF-\u03b2 signaling","volume":"143","author":"Siddiqui","year":"2021","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2026.117898_bb0075","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.4049\/jimmunol.0802812","article-title":"Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan a","volume":"183","author":"Takahashi","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2026.117898_bb0080","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1387\/ijdb.041816fl","article-title":"Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues","volume":"48","author":"Liu","year":"2004","journal-title":"Int. J. Dev. Biol."},{"issue":"9","key":"10.1016\/j.bone.2026.117898_bb0085","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/jbmr.4415","article-title":"Sites of Cre-recombinase activity in mouse lines targeting skeletal cells","volume":"36","author":"Couasnay","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117898_bb0090","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2026.117898_bb0095","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/jcp.22879","article-title":"Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation","volume":"227","author":"Sul","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.bone.2026.117898_bb0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm.1945","article-title":"Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis","volume":"15","author":"Binder","year":"2009","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bone.2026.117898_bb0105","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s11914-019-00545-7","article-title":"Monocyte chemoattractant protein-1 (MCP-1\/CCL2) drives activation of bone remodelling and skeletal metastasis","volume":"17","author":"Mulholland","year":"2019","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"10.1016\/j.bone.2026.117898_bb0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2008.08.120","article-title":"Gene expression profile of the bone microenvironment in human fragility fracture bone","volume":"44","author":"Hopwood","year":"2009","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.bone.2026.117898_bb0115","first-page":"2173","article-title":"Elevated CCL2\/MCP-1 levels are related to disease severity in postmenopausal osteoporotic patients","volume":"62","author":"Yang","year":"2016","journal-title":"Clin. Lab."},{"issue":"6","key":"10.1016\/j.bone.2026.117898_bb0120","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00223-013-9718-6","article-title":"MCP-1 expression is specifically regulated during activation of skeletal repair and remodeling","volume":"92","author":"Wu","year":"2013","journal-title":"Calcif. Tissue Int."},{"issue":"24","key":"10.1016\/j.bone.2026.117898_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70300","article-title":"CCL2\/CCR2 signalling in mesenchymal stem\/progenitor cell recruitment and fracture healing in mice","volume":"28","author":"Kannan","year":"2024","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"10.1016\/j.bone.2026.117898_bb0130","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002808RR","article-title":"CCL2 is a critical mechano-responsive mediator in crosstalk between osteoblasts and bone mesenchymal stromal cells","volume":"35","author":"Yao","year":"2021","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.bone.2026.117898_bb0135","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s12276-020-0484-z","article-title":"The M-CSF receptor in osteoclasts and beyond","volume":"52","author":"Mun","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.bone.2026.117898_bb0140","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.1002\/jcp.30375","article-title":"The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases","volume":"236","author":"Zhu","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.bone.2026.117898_bb0145","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/os.13252","article-title":"Bindarit reduces bone loss in ovariectomized mice by inhibiting CCL2 and CCL7 expression via the NF-\u03baB signaling pathway","volume":"14","author":"Yuan","year":"2022","journal-title":"Orthop. Surg."},{"issue":"12","key":"10.1016\/j.bone.2026.117898_bb0150","article-title":"Preventive CCL2\/CCR2 axis blockade suppresses osteoclast activity in a mouse model of rheumatoid arthritis by reducing homing of CCR2hi osteoclast progenitors to the affected bone","volume":"3","author":"Flegar","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bone.2026.117898_bb0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jcb.24663","article-title":"Dominant negative MCP-1 blocks human osteoclast differentiation","volume":"115","author":"Morrison","year":"2014","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.bone.2026.117898_bb0160","first-page":"7760","article-title":"Mutant monocyte chemoattractant protein-1 protein (7ND) inhibits osteoclast differentiation and reduces oral squamous carcinoma cell bone invasion","volume":"15","author":"Luo","year":"2018","journal-title":"Oncol. Lett."},{"issue":"15","key":"10.1016\/j.bone.2026.117898_bb0165","article-title":"The inhibitory effects of 7ND protein on osteoclast differentiation in apical periodontitis","volume":"27","author":"Ji","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"15","key":"10.1016\/j.bone.2026.117898_bb0170","article-title":"The role and therapeutic targeting of the CCL2\/CCR2 signaling axis in inflammatory and fibrotic diseases","volume":"9","author":"Guo","year":"2025","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.bone.2026.117898_bb0175","article-title":"Role of the CCL2-CCR2 axis in cardiovascular disease: pathogenesis and clinical implications","volume":"30","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.bone.2026.117898_bb0180","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13115","article-title":"Role of the CCL2-CCR2 signalling axis in cancer: mechanisms and therapeutic targeting","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Prolif."},{"issue":"17","key":"10.1016\/j.bone.2026.117898_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174251","article-title":"CC chemokine ligand-2: a promising target for overcoming anticancer drug resistance","volume":"14","author":"Shi","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:36:17Z","timestamp":1779248177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"alternative-id":["S8756328226001249"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.117898","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anabolic effect of parathyroid hormone (1\u201334) to prevent ovariectomy induced bone loss is attenuated in Col1A1-cre floxed monocyte chemotactic protein 1 (MCP1, CCL2) mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.117898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117898"}}